Impact Factor
3.86
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.80
2,125 total citations
h5-index
59
h5 depth signal
Cited share
71.4%
406 of 569
Total citations
2,125
Citation footprint
Metric signal
3.52
External metric anchor
Self-citation
5.4%
115 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
2,744
Canada
435
United Kingdom
272
Australia
183
Germany
106
Citing Fields of Research
Respiratory Support
1,182
Allergies
655
Lung Cancer
513
Auto-Inflammatory Disorders
344
Cystic Fibrosis
295
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,774
Articles tracked across the journal lifetime
Indexed publication set
569
406 cited publications
Last 12 months
428
35.7 publications/month
Open access share
33.6%
144 OA publications in the last year
Leading citing country
United States
2,744 citing publications
Leading citing field
Respiratory Support
1,182 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v10n1, 2013-
v10n1, 2013-
Active Coverage
Research Focus & Classification
Indexed Subjects
Respiratory Support
Allergies
Chronobiology
Lung Cancer
Cystic Fibrosis
Auto-Inflammatory Disorders
Issuing & Sponsoring Bodies
issuing body
American Thoracic Society
Broad Categories
Pulmonary Medicine
Allergies
Chronobiology
Cystic Fibrosis
Auto-Inflammatory Disorders
Respiratory Support
Lung Cancer
MeSH Descriptors
Respiratory Tract Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/annalsats/aaoag305
Open DOI
A Proposed Consensus Definition of Severe COPD: a modified Delphi Study
Rationale: Advanced interventions are available for patients with more severe COPD despite guideline-recommended therapies, yet this population is heterogeneously defined and inconsistently recognized, and a standardized work-up is lacki...
02
DOI 10.1093/annalsats/aaoag323
Open DOI
International patterns and incidence trends of lung cancer in adolescent and young adults by histological subtype and sex
Background: Lung cancer in adolescents and young adults (AYAs) presents distinct features compared to older populations. Methods: This population-based study utilized GLOBOCAN 2022 data to estimate lung cancer age-standardized incidence ...
03
DOI 10.1093/annalsats/aaoag325
Open DOI
Differential effects of PM2.5 constituents on tuberculosis infection and disease progression in 40,379 student close contacts
Rationale: Outdoor PM2.5 has been increasingly implicated in tuberculosis, yet evidence has largely focused on total PM2.5 mass and has usually considered Mycobacterium tuberculosis (M. tuberculosis) infection and active tuberculosis sep...
04
DOI 10.1093/annalsats/aaoag320
Open DOI
Quantitative CT in the real-world evaluation of progressive pulmonary fibrosis; the REVISE PPF multicentre observational study
Rationale and Objective: We assessed whether an FDA-cleared quantitative CT (qCT) tool (Brainomix, e-Lung) identifies progressive pulmonary fibrosis (PPF) earlier than routine clinical diagnosis and evaluated the prognostic value of base...
05
DOI 10.1093/annalsats/aaoag317
Open DOI
Are Short-Term Increases in PM₂.₅ Linked to Respiratory Hospitalizations in IPF?
06
DOI 10.1093/annalsats/aaoag318
Open DOI
Not Just a Breathing Problem: Fall Injuries in Long-Term Oxygen Therapy
07
DOI 10.1093/annalsats/aaoag315
Open DOI
Longitudinal Functional Magnetic Resonance Imaging to Assess Lung Disease in Cystic Fibrosis
Rationale: Matrix pencil decomposition magnetic resonance imaging (MP-MRI) enables quantitative assessment of lung ventilation and perfusion and was shown to correlate with contrast-enhanced (CE) perfusion MRI. Objectives: To determine t...
08
DOI 10.1093/annalsats/aaoag310
Open DOI
Bronchiectasis prevalence, incidence, and exacerbation rates among insured adults in the U.S.: a descriptive analysis
Rationale: Contemporary population-representative data on bronchiectasis epidemiology in the United States remain limited. Existing exacerbation estimates are derived primarily from referral registries that overrepresent severe disease u...
09
10
Bibliographical & Catalog Notes
Also issued in print, 2017-2021.